20-33659963-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_031232.4(NECAB3):c.565G>A(p.Gly189Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000271 in 1,562,136 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_031232.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000624 AC: 95AN: 152176Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000273 AC: 45AN: 164558Hom.: 0 AF XY: 0.000235 AC XY: 21AN XY: 89490
GnomAD4 exome AF: 0.000233 AC: 328AN: 1409842Hom.: 2 Cov.: 33 AF XY: 0.000235 AC XY: 164AN XY: 697174
GnomAD4 genome AF: 0.000624 AC: 95AN: 152294Hom.: 0 Cov.: 33 AF XY: 0.000551 AC XY: 41AN XY: 74472
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.565G>A (p.G189S) alteration is located in exon 7 (coding exon 7) of the NECAB3 gene. This alteration results from a G to A substitution at nucleotide position 565, causing the glycine (G) at amino acid position 189 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at